Evidence map›Paper›PMID 33122860›Full record

ArticleNature medicine2021

Wearable sensor data and self-reported symptoms for COVID-19 detection.

Giorgio Quer, Jennifer M Radin, Matteo Gadaleta, Katie Baca-Motes, Lauren Ariniello, Edward Ramos, Vik Kheterpal, Eric J Topol, Steven R Steinhubl

Registry-linked trialOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Nature medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05290792 (Use of Wearable Sensors for Early Detection and Tracking of Viral Respiratory Tract Infections), which is not on this map. Cited by 234 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
234citing papers in PubMed, 6 pooled it
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05290792 nacompletednot on this map

Use of Wearable Sensors for Early Detection and Tracking of Viral Respiratory Tract Infections: The WE SENSE Study

TypeinterventionalSponsorEmily McDonaldRan2021 to 2022Enrolled56ConditionsViral Respiratory Tract Infection, InfluenzaArmsAdministration of FluMist (Live Attenuated Influenza Vaccine)
3 · Its place in the literature

Who cites it

234 citing papers in PubMed, 6 syntheses or guidelines pooled it, 472 citations in OpenAlex.

  1. Pooled it
  2. Unsupervised home spirometryEuropean respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Observational
  18. Article
  19. Article
  20. Review

174 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Giorgio Quer *Scripps Research Translational Institute, La Jolla, CA, USA. gquer@scripps.edu.ORCID http://orcid.org/0000-0003-2208-7912
Jennifer M Radin *Scripps Research Translational Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-3843-0842
Matteo Gadaleta *Scripps Research Translational Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0001-6470-6537
Katie Baca-MotesScripps Research Translational Institute, La Jolla, CA, USA.
Lauren ArinielloScripps Research Translational Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-6005-8824
Edward RamosScripps Research Translational Institute, La Jolla, CA, USA.
Vik KheterpalCareEvolution, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-4752-4229
Eric J TopolScripps Research Translational Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-1478-4729
Steven R SteinhublScripps Research Translational Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-9256-7914
Scripps Research Institute · USCareEvolution (United States) · US

Funding

Scripps Translational Science InstituteUL1TR002550 · NCATS · SCRIPPS RESEARCH INSTITUTE, THE · PI TOPOL, ERIC JEFFREY · 2018 to 2022
$28.9M
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (NCATS) UL1TR002550
6 · The paper itself

Abstract

Traditional screening for COVID-19 typically includes survey questions about symptoms and travel history, as well as temperature measurements. Here, we explore whether personal sensor data collected over time may help identify subtle changes indicating an infection, such as in patients with COVID-19. We have developed a smartphone app that collects smartwatch and activity tracker data, as well as self-reported symptoms and diagnostic testing results, from individuals in the United States, and have assessed whether symptom and sensor data can differentiate COVID-19 positive versus negative cases in symptomatic individuals. We enrolled 30,529 participants between 25 March and 7 June 2020, of whom 3,811 reported symptoms. Of these symptomatic individuals, 54 reported testing positive and 279 negative for COVID-19. We found that a combination of symptom and sensor data resulted in an area under the curve (AUC) of 0.80 (interquartile range (IQR): 0.73-0.86) for discriminating between symptomatic individuals who were positive or negative for COVID-19, a performance that is significantly better (P < 0.01) than a model

Indexed as

Wearable Electronic DevicesAdultAgedCarrier StateCOVID-19FemaleHeart RateHumansMaleMass ScreeningMiddle AgedMonitoring, PhysiologicSelf ReportSleepUnited States

Identifiers

PMID33122860
OpenAlexW3095708005

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.